DE4132925A1 - Medical plaster - incorporates lead@ layer for absorbing gamma-or X=ray radiation to protect ambience of patient undergoing radioisotope therapy - Google Patents

Medical plaster - incorporates lead@ layer for absorbing gamma-or X=ray radiation to protect ambience of patient undergoing radioisotope therapy

Info

Publication number
DE4132925A1
DE4132925A1 DE4132925A DE4132925A DE4132925A1 DE 4132925 A1 DE4132925 A1 DE 4132925A1 DE 4132925 A DE4132925 A DE 4132925A DE 4132925 A DE4132925 A DE 4132925A DE 4132925 A1 DE4132925 A1 DE 4132925A1
Authority
DE
Germany
Prior art keywords
layer
plaster
protect
lead
ray radiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE4132925A
Other languages
German (de)
Inventor
Walter Dipl Phys Dr Birg
Christoph B Prof Dr Ostertag
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIRG WALTER
Original Assignee
BIRG WALTER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIRG WALTER filed Critical BIRG WALTER
Priority to DE4132925A priority Critical patent/DE4132925A1/en
Publication of DE4132925A1 publication Critical patent/DE4132925A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1028X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy using radiation sources applied onto the body
    • A61N5/1029Radioactive dressings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/00051Accessories for dressings
    • A61F13/00072Packaging of dressings
    • A61F13/00076Packaging of adhesive dressings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive plasters or dressings
    • A61F13/023Adhesive plasters or dressings wound covering film layers without a fluid handling layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1279Plasters, bandages, dressings, patches or adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00361Plasters
    • A61F2013/00365Plasters use
    • A61F2013/00387Plasters use skin protection
    • A61F2013/00391Plasters use skin protection from irradiation, e.g. sun
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00361Plasters
    • A61F2013/00902Plasters containing means
    • A61F2013/00936Plasters containing means metal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092Details
    • A61N2005/1094Shielding, protecting against radiation

Abstract

The medical plaster incorporates a lead layer which absorbs gamma or X-ray radiation. This lead layer is either smooth or with greater thicknesses is folded or laminated so that the plaster can conform to the body contours of the patient. On its packaging the plaster carries an indication of the absorption value of the clinically most important isotope. The plaster has at its base a wound-covering layer with adhesive zones, above which is the lead absorbing layer. There is an intermediate layer of cellular material, and an outer plastic covering. ADVANTAGE - To protect the ambiance of a patient being treated with a radio-isotope therapy.

Description

In der modernen Therapie der Hirntumoren wird oft eine Implantation von Radionukliden durchgeführt. Dabei wird mittels einer kleinen Kanüle ein Radioisotop in das Zentrum des Tumors eingebracht und der Tumor von innen zerstrahlt. Die dabei auftretende Strahlung, insbesondere an der Stelle des Trepanationsloches von 8-15 mm Durchmesser, führt jedoch auch zu einer Strahlenbelastung der Umwelt. Daher ist es geboten, diese nach außen dringende Strahlung abzuschirmen. Durch ein Pflaster, - wie in Abb. 1 dargestellt - das ein strahlenabsorbierendes Medium enthält (Blei od. ähnliches) kann bei dem heute vorwiegend verwendeten Isotop I-125 eine praktisch vollständige Absorption erreicht werden. Damit können die Patienten wieder am normalen Leben teilnehmen, was sonst nur mit Einschränkung bzw. mit einer bestimmten Strahlenbelastung der Umwelt möglich wäre.In modern therapy of brain tumors, radionuclides are often implanted. A radioisotope is inserted into the center of the tumor using a small cannula and the tumor is blasted from the inside. However, the radiation that occurs, particularly at the location of the trepanation hole with a diameter of 8-15 mm, also leads to radiation pollution of the environment. It is therefore necessary to shield this radiation, which penetrates outwards. A plaster, as shown in Fig. 1, which contains a radiation-absorbing medium (lead or the like) can be used to achieve practically complete absorption in the isotope I-125, which is predominantly used today. This enables patients to participate in normal life again, which would otherwise only be possible with restrictions or with a certain radiation exposure to the environment.

Da das Isotop I-125 Photonen mit Gammaenergien zwischen 29 und 35 KeV emittiert, ist im einfachsten Falle das Pflaster auf diesen Energiebereich ausgelegt. Da die Halbwertsschicht für Blei bei diesen Energien rund 0.025 mm beträgt und zehn Halbwertsschichten eine Herabsetzung der Strahlung auf rund ein Promille bewirken, kann mit einer Schichtdicke von 2 mm ein fast vollständiger Schutz der Umwelt erreicht werden. Dabei ist wichtig, daß sich auf der Pflasterverpackung eine genaue Bezeichnung über die Strahlenschutzwerte befindet.Since the isotope I-125 photons with gamma energies between 29 and 35 KeV is emitted, in the simplest case the patch is on this Energy range designed. Since the half-value layer for lead at these energies is around 0.025 mm and ten half-value layers cause the radiation to be reduced to around one per thousand, can provide almost complete protection with a layer thickness of 2 mm of the environment. It is important that the A precise description of the plaster packaging Radiation protection values.

Umgekehrt kann mit dem Pflaster auch eine aus therapeutischen Gründen von außen erfolgende Bestrahlung so optimiert werden, das bestimmte Hautregionen des Patienten eine definiert geringere Dosis erhalten.Conversely, the patch can also be used for therapeutic purposes Reasons from outside radiation are optimized so that certain areas of the patient's skin have a defined lower dose receive.

Gemäß den verschiedenen Anwendungen sind eine Reihe von Ausführungen möglich. In Abb. 1 ist eine der denkbaren Ausführungen dargestellt: 1 - Klebezone, 2 - Pflasterabdeckung, 3 - absorbierende Schicht, entweder mehrlagig oder - bei höherer Schichtdicke, gegliedert wie dargestellt in Abb. 2. In letzterem Falle besteht die Absorberschicht - wegen der notwendigen Anpassung an die Körperkonturen des Patienten - aus einzelnen Lamellen, die überlappend angeordnet sind, wie Abb. 2 im seitlichen Schnitt zeigt. 4 - Zwischenschicht aus Plastik- oder Zellstoff-Folie, 5 - wundversorgende Pflasterschicht. Es ist auch ein Ausführung denkbar, bei der das Pflaster in Form einer Tasche ausgeführt ist, so daß ein oder mehrere Absorptionsfolien eingelegt werden können.A number of designs are possible according to the different applications. In Fig. 1 one of the conceivable versions is shown: 1 - adhesive zone, 2 - plaster cover, 3 - absorbent layer, either multi-layer or - with a higher layer thickness, structured as shown in Fig. 2. In the latter case, the absorber layer exists - because of the necessary Adaptation to the body contours of the patient - from individual lamellae, which are arranged overlapping, as Fig. 2 shows in the lateral section. 4 - intermediate layer made of plastic or cellulose film, 5 - wound-dressing plaster layer. An embodiment is also conceivable in which the plaster is designed in the form of a pocket, so that one or more absorption foils can be inserted.

Claims (3)

1. Medizinisches Pflaster, das eine Gamma- oder Röntgenstrahlung absorbierende Schicht - z. B. aus Bleifolie - enthält.1. Medical patch that contains gamma or x-rays absorbent layer - e.g. B. from lead foil - contains. 2. Medizinisches Pflaster nach 1) bei dem die strahlenabsorbierende Schicht entweder glatt oder bei größerer Dicke gefalzt oder lamellenförmig-mehrlagig ist, so daß das Pflaster den Körperkonturen des Patienten angepaßt werden kann.2. Medical plaster according to 1) in which the radiation-absorbing Layer either smooth or folded or thicker is lamellar multilayer, so that the plaster Body contours of the patient can be adjusted. 3. Medizinisches Pflaster gemäß Ansprüchen 1) und 2), das auf seiner Verpackung die Absorptionswerte für die klinisch wichtigsten Isotope aufgedruckt enthält.3. Medical plaster according to claims 1) and 2) on his Packing the absorption values for the clinically most important Contains printed isotopes.
DE4132925A 1991-10-04 1991-10-04 Medical plaster - incorporates lead@ layer for absorbing gamma-or X=ray radiation to protect ambience of patient undergoing radioisotope therapy Withdrawn DE4132925A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE4132925A DE4132925A1 (en) 1991-10-04 1991-10-04 Medical plaster - incorporates lead@ layer for absorbing gamma-or X=ray radiation to protect ambience of patient undergoing radioisotope therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4132925A DE4132925A1 (en) 1991-10-04 1991-10-04 Medical plaster - incorporates lead@ layer for absorbing gamma-or X=ray radiation to protect ambience of patient undergoing radioisotope therapy

Publications (1)

Publication Number Publication Date
DE4132925A1 true DE4132925A1 (en) 1993-04-08

Family

ID=6442047

Family Applications (1)

Application Number Title Priority Date Filing Date
DE4132925A Withdrawn DE4132925A1 (en) 1991-10-04 1991-10-04 Medical plaster - incorporates lead@ layer for absorbing gamma-or X=ray radiation to protect ambience of patient undergoing radioisotope therapy

Country Status (1)

Country Link
DE (1) DE4132925A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0730873A1 (en) * 1995-03-07 1996-09-11 Korea Atomic Energy Research Institute A radioactive patch/film and process for preparation thereof
DE29716589U1 (en) * 1997-09-16 1997-11-27 Evers Henning band Aid
EP1237624A1 (en) * 1999-11-18 2002-09-11 Howard L. Schrayer Device for the inhibition of cellular proliferation
WO2012154962A2 (en) 2011-05-11 2012-11-15 Stemrad Ltd. Radiation protection device and methods thereof
EP2583645A1 (en) * 2011-10-21 2013-04-24 Josek Berek Apolet Skin lesion protector
CN106730307A (en) * 2017-01-04 2017-05-31 成都维宁生物技术有限公司 Conformal therapy is pasted and its Manufacturing approach and use
US10276273B2 (en) 2015-03-17 2019-04-30 Stemrad Ltd. Device and method for protection from radiation in space
US11276505B2 (en) 2017-08-02 2022-03-15 Stemrad Ltd. Material configuration enabling flexibility of a structure using rigid components
CN115670794A (en) * 2022-11-22 2023-02-03 安徽省德济堂药业有限公司 High-water-absorption plaster and processing equipment thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1190733A (en) * 1966-04-16 1970-05-06 Johnson & Johnson Improvements in and relating to Surgical Swabs
US4715366A (en) * 1986-04-21 1987-12-29 Edward Teeple Surgical shield
US4901738A (en) * 1987-03-31 1990-02-20 Minnesota Mining And Manufacturing Company Laser shield

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1190733A (en) * 1966-04-16 1970-05-06 Johnson & Johnson Improvements in and relating to Surgical Swabs
US4715366A (en) * 1986-04-21 1987-12-29 Edward Teeple Surgical shield
US4901738A (en) * 1987-03-31 1990-02-20 Minnesota Mining And Manufacturing Company Laser shield

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Derwent CPI-Referat 89-309702/42 *

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0730873A1 (en) * 1995-03-07 1996-09-11 Korea Atomic Energy Research Institute A radioactive patch/film and process for preparation thereof
DE29716589U1 (en) * 1997-09-16 1997-11-27 Evers Henning band Aid
EP1237624A1 (en) * 1999-11-18 2002-09-11 Howard L. Schrayer Device for the inhibition of cellular proliferation
EP1237624A4 (en) * 1999-11-18 2003-07-30 Howard L Schrayer Device for the inhibition of cellular proliferation
US20150004131A1 (en) * 2011-05-11 2015-01-01 Oren MILSTEIN Radiation protection device and methods thereof
WO2012154962A2 (en) 2011-05-11 2012-11-15 Stemrad Ltd. Radiation protection device and methods thereof
US10600524B2 (en) * 2011-05-11 2020-03-24 Stemrad Ltd. Radiation protection device and methods thereof
EP2706881A2 (en) * 2011-05-11 2014-03-19 Stemrad Ltd. Radiation protection device and methods thereof
CN103841848A (en) * 2011-05-11 2014-06-04 施特姆拉德有限公司 Radiation protection device and methods thereof
EP2706881A4 (en) * 2011-05-11 2014-10-15 Stemrad Ltd Radiation protection device and methods thereof
EP2583645A1 (en) * 2011-10-21 2013-04-24 Josek Berek Apolet Skin lesion protector
AU2012324792B2 (en) * 2011-10-21 2015-12-24 Josek Berek Apolet Skin lesion protector
WO2013057309A1 (en) * 2011-10-21 2013-04-25 Apolet Josek Berek Skin lesion protector
US10276273B2 (en) 2015-03-17 2019-04-30 Stemrad Ltd. Device and method for protection from radiation in space
US10790068B2 (en) 2015-03-17 2020-09-29 Stemrad Ltd. Device and method for protection from radiation in space
US11222733B2 (en) 2015-03-17 2022-01-11 Stemrad Ltd. Device and method for protection from radiation in space
CN106730307A (en) * 2017-01-04 2017-05-31 成都维宁生物技术有限公司 Conformal therapy is pasted and its Manufacturing approach and use
US11276505B2 (en) 2017-08-02 2022-03-15 Stemrad Ltd. Material configuration enabling flexibility of a structure using rigid components
US11769601B2 (en) 2017-08-02 2023-09-26 Stemrad Ltd. Material, configuration enabling flexibility of a structure using rigid components
CN115670794A (en) * 2022-11-22 2023-02-03 安徽省德济堂药业有限公司 High-water-absorption plaster and processing equipment thereof

Similar Documents

Publication Publication Date Title
US3351049A (en) Therapeutic metal seed containing within a radioactive isotope disposed on a carrier and method of manufacture
US4510924A (en) Brachytherapy devices and methods employing americium-241
US5871708A (en) Radioactive patch/film and process for preparation thereof
Laughlin et al. Choice of optimum megavoltage for accelerators for photon beam treatment
DE4132925A1 (en) Medical plaster - incorporates lead@ layer for absorbing gamma-or X=ray radiation to protect ambience of patient undergoing radioisotope therapy
EP3348243B1 (en) Spectacles for holding at least one radiation protection material
Henschke et al. Cesium-131 seeds for permanent implants
US7530941B2 (en) X-ray and gamma ray emitting temporary high dose rate brachytherapy source
US6440058B1 (en) Radioactive seeds and method for using same
Orton et al. Time-dose factor (TDF) analysis of dose rate effects in permanent implant dosimetry
Gazda et al. Principles of radiation therapy
Muller‐Runkel et al. Monitoring the radiation dose to a multiprogrammable pacemaker during radical radiation therapy: a case report
DE2002620A1 (en) Radiation source with inner shield for medical purposes
CA2171124C (en) A radioactive patch/film and process for preparation thereof
Singh et al. Principles and practice of radiation oncology
Maruyama et al. Work in progress: 252Cf neutron brachytherapy for hemispheric malignant glioma.
WO1999056828A1 (en) Catheter or vessel support with radiation sensitizer and corresponding production method
Dávila et al. Assessment of the effectiveness of attenuation of Pb aprons by using TLD dosimetry and Monte Carlo calculations
Haybittle A 24 curie strontium 90 unit for whole-body superficial irradiation with beta rays
Walz et al. Individualized compensating filters and dose optimization in pelvic irradiation
Karthik et al. Radiotherapy for Head and Neck cancers-a review
US20230117131A1 (en) Optimization of Radionuclides for Treatment of Cutaneous Lesions
Ghosh Radio therapeutic techniques in medicine
Sharma Strontium-90 eye application
KR20220155993A (en) Apparatus and method for reducing radiation exposure from x-ray tubes

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8122 Nonbinding interest in granting licences declared
8139 Disposal/non-payment of the annual fee